Ankaferd Blood Stopper for Controlling Gastrointestinal Bleeding due to Distinct Benign Lesions Refractory to Conventional Antihemorrhagic Measures | Zendy

Mevlüt Kurt | Zendy; İbrahi̇m Koral Önal | Zendy; Meral Akdoğan | Zendy; Murat Kekilli | Zendy; Mehmet Arhan | Zendy; Abdurrahim Sayılır | Zendy; Erkin Öztaş | Zendy; İbrahim C. Haznedaroğlu | Zendy

Open Access

Ankaferd Blood Stopper for Controlling Gastrointestinal Bleeding due to Distinct Benign Lesions Refractory to Conventional Antihemorrhagic Measures

Author(s) -

Mevlüt Kurt,

İbrahi̇m Koral Önal,

Meral Akdoğan,

Murat Kekilli,

Mehmet Arhan,

Abdurrahim Sayılır,

Erkin Öztaş,

İbrahim C. Haznedaroğlu

Publication year - 2010

Publication title -

canadian journal of gastroenterology

Language(s) - English

Resource type - Journals

eISSN - 1916-7237

pISSN - 0835-7900

DOI - 10.1155/2010/896819

Subject(s) - medicine , hemostasis , refractory (planetary science) , hemostatic agent , surgery , gastrointestinal bleeding , hemostatics , endoscopy , physics , astrobiology

To assess the hemostatic efficacy of the Ankaferd Blood Stopper (ABS, Ankaferd Health Products Ltd, Turkey) hemostatic agent for controlling gastrointestinal bleeding associated with various benign lesions refractory to conventional antihemorrhagic measures.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research